Texas Man Charged with Conspiracy to Obtain Controlled Substances by Fraud

A federal grand jury in the Middle District of Louisiana returned an indictment today charging a Texas man with a scheme to obtain controlled substances from multiple pharmacies using fraudulent prescriptions and then sell those drugs on the street.

According to court documents, Darrion Denard Brooks, 28, of Houston, and co-conspirators, used fictitious identification information to obtain fraudulent prescriptions for controlled substances on behalf of patients who either did not exist or for whom medical providers did not authorize the prescriptions. As alleged in the indictment, from November 2023 through March 2025, Brooks and his co-conspirators fraudulently obtained controlled substances from pharmacies in the Baton Rouge area and elsewhere using prescriptions obtained using the Drug Enforcement Administration (DEA) registration numbers and other identifying information of at least five medical professionals without their authority. It is alleged that through this scheme, Brooks and his co-conspirators obtained at least 11 fraudulent prescriptions for codeine and other controlled substances from at least eight different pharmacies in Louisiana, Texas, Florida, Georgia and Tennessee.

Brooks is charged with one count of conspiracy to acquire and obtain controlled substances by fraud and to possess with the intent to distribute controlled substances, and four counts of obtaining possession of controlled substances by fraud. If convicted, he faces a maximum penalty of four years in prison per count. A federal judge will determine any sentence after considering the U.S. Sentencing Guidelines and other statutory factors.

Acting Assistant Attorney General Matthew R. Galeotti of the Justice Department’s Criminal Division; U.S. Attorney Kurt L. Wall for the Middle District of Louisiana; Assistant Administrator Cheri Oz of the DEA Diversion Control Division; and Deputy Inspector General for Investigations Christian J. Schrank of the Department of Health and Human Services, Office of Inspector General (HHS-OIG) made the announcement.

DEA and HHS-OIG are investigating the case.

Trial Attorney Zakeria A. Haidary of the Criminal Division’s Fraud Section and Assistant U.S. Attorney Kristen L. Craig for the Middle District of Louisiana are prosecuting the case.

The Fraud Section leads the Criminal Division’s efforts to combat health care fraud through the Health Care Fraud Strike Force Program. Since March 2007, this program, currently comprised of nine strike forces operating in 27 federal districts, has charged more than 5,800 defendants who collectively have billed federal health care programs and private insurers more than $30 billion. In addition, the Centers for Medicare & Medicaid Services, working in conjunction with HHS-OIG, are taking steps to hold providers accountable for their involvement in health care fraud schemes. More information can be found at www.justice.gov/criminal-fraud/health-care-fraud-unit.

An indictment is merely an allegation. All defendants are presumed innocent until proven guilty beyond a reasonable doubt in a court of law.